07/22/2024
7:33 AM | Hepion Pharmaceuticals, Inc. (Subject)
Hepion Pharmaceuticals (Subject)
| Form 425 | |
07/22/2024
7:28 AM | Hepion Pharmaceuticals, Inc. (Filer)
Hepion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/15/2024
11:15 PM | Hepion Pharmaceuticals, Inc. (Filer)
Hepion Pharmaceuticals (Filer)
| Form EFFECT | |
07/15/2024
4:17 PM | Hepion Pharmaceuticals, Inc. (Filer)
Hepion Pharmaceuticals (Filer)
| Form 424B3 | |
07/11/2024
8:46 AM | Hepion Pharmaceuticals, Inc. (Filer)
Hepion Pharmaceuticals (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
06/24/2024
6:07 PM | Hepion Pharmaceuticals, Inc. (Filer)
Hepion Pharmaceuticals (Filer)
| Form 10-K/A | |
05/21/2024
4:08 PM | Hepion Pharmaceuticals, Inc. (Filer)
Hepion Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
|
05/15/2024
3:46 PM | Hepion Pharmaceuticals, Inc. (Filer)
Hepion Pharmaceuticals (Filer)
| Form NT 10-Q | |
04/16/2024
3:53 PM | Hepion Pharmaceuticals, Inc. (Filer)
Hepion Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
04/01/2024
3:30 PM | Hepion Pharmaceuticals, Inc. (Filer)
Hepion Pharmaceuticals (Filer)
| Form NT 10-K | |
03/06/2024
3:30 PM | Hepion Pharmaceuticals, Inc. (Issuer)
Hepion Pharmaceuticals (Issuer)
Purcell Michael J. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/06/2024
3:15 PM | Hepion Pharmaceuticals, Inc. (Filer)
Hepion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/21/2024
7:01 PM | BRANCACCIO JOHN P (Reporting)
Hepion Pharmaceuticals, Inc. (Issuer)
Hepion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
7:01 PM | Hepion Pharmaceuticals, Inc. (Issuer)
Hepion Pharmaceuticals (Issuer)
Lbiati Kaouthar (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
7:01 PM | Hepion Pharmaceuticals, Inc. (Issuer)
Hepion Pharmaceuticals (Issuer)
JACOB GARY S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
7:01 PM | Block Timothy M. (Reporting)
Hepion Pharmaceuticals, Inc. (Issuer)
Hepion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
8:02 AM | Hepion Pharmaceuticals, Inc. (Filer)
Hepion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
2:38 PM | ARMISTICE CAPITAL, LLC (Filed by)
Hepion Pharmaceuticals, Inc. (Subject)
Hepion Pharmaceuticals (Subject)
| Form SC 13G | |
01/03/2024
3:30 PM | Hepion Pharmaceuticals, Inc. (Filer)
Hepion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/07/2023
7:41 AM | Hepion Pharmaceuticals, Inc. (Filer)
Hepion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/28/2023
5:55 AM | Hepion Pharmaceuticals, Inc. (Issuer)
Hepion Pharmaceuticals (Issuer)
Wijngaard Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2023
11:15 PM | Hepion Pharmaceuticals, Inc. (Filer)
Hepion Pharmaceuticals (Filer)
| Form EFFECT | |
10/03/2023
4:22 PM | Hepion Pharmaceuticals, Inc. (Filer)
Hepion Pharmaceuticals (Filer)
| Form D
Notice of Exempt Offering of Securities | |
09/20/2023
10:27 AM | Hepion Pharmaceuticals, Inc. (Issuer)
Hepion Pharmaceuticals (Issuer)
Wijngaard Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/19/2023
8:01 AM | Foster Robert T (Reporting)
Hepion Pharmaceuticals, Inc. (Issuer)
Hepion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2023
7:00 AM | Foster Robert T (Reporting)
Hepion Pharmaceuticals, Inc. (Issuer)
Hepion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/06/2023
3:40 PM | Hepion Pharmaceuticals, Inc. (Filer)
Hepion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
